FDA Approves Tecfidera for Multiple Sclerosis
On March 27, 2013 the U.S. Food and Drug Administration announced approval of a new drug to treat multiple sclerosis. The drug, Tecfidera (dimethyl fumarate) is approved for use in adult patients relapsing multiple sclerosis (MS). Tecfidera will be launched in 120 mg and 240 mg delayed release capsule formulations. While the exact mechanism of […]